Who owns DCC HEALTHCARE?

DCC HEALTHCARE has been 100% owned by INVESTCorporate since September 2025.

At what enterprise value was DCC HEALTHCARE acquired in 2025?

During the acquisition of DCC HEALTHCARE by INVESTCorporate in 2025, the transaction's Enterprise Value is estimated to be in the range of 1b - 4b GBP.

When was DCC HEALTHCARE acquired by INVESTCorporate?

DCC HEALTHCARE was acquired by INVESTCorporate in 2025.

What was the revenue of DCC HEALTHCARE at the time of the deal?

The revenue of DCC HEALTHCARE at the time of the deal is estimated to be in the range of 450M - 900M GBP.

How is the data for the DCC HEALTHCARE acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the DCC HEALTHCARE deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.investindustrial.com/publications/news/Investindustrial-agrees-to-acquire-DCC-Healthcare-from-DCC-PLC--an-Irish-incorporated--UK-listed-company.html

What is the average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026?

The average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026 is 14.5x.

← DATABASE

Home Database Healthcare & PharmaDCC HEALTHCARE

09/2025

DCC HEALTHCARE acquired by INVESTCorporate

UNITED KINGDOM Life Sciences / Pharma & Biotech / CDMO EV 1b - 4b GBP

Context

InvestIndustrial finalized the acquisition of DCC Healthcare Limited from the London-listed group DCC plc. This transaction is a strategic corporate carve-out designed to simplify DCC plc's operations, allowing the group to focus resources on its largest and most profitable Energy division. The proceeds from the sale are earmarked for distribution to DCC shareholders. The deal received regulatory approval from the European Commission.

DCC HEALTHCARE, which reported an EBITDA margin of in 2024, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (14.5x).

-> Deep-dive in Healthcare & Pharma market trends

Target

DCC Healthcare is a leading healthcare business providing products and services to health and beauty brand owners and healthcare providers. It operates as a CDMO (Contract Development and Manufacturing Organization) and distributes medical devices and pharma products.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (GBP)

Year

Rev

EBITDA

EBIT

2024

2023

Similar deals in Life Sciences

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
11/2025	ARLANE	DESSINTEY	FRANCE	Medical Devices
10/2025	PUBLIC MARKETS (IPO)	OTTOBOCK	GERMANY	Implants & Prosthetics
09/2025	CAPVEST PARTNERS	STADA	GERMANY	Generics / Labs
09/2025	CREDIT MUTUEL EQUITY / EURAZEO / BPIFRANCE / BNP PARIBAS DEVELOPPEMENT	PROTEOR	FRANCE	Implants & Prosthetics
08/2025	LGT CAPITAL PARTNERS	NEMERA	FRANCE	Medical Consumables
08/2025	PAI PARTNERS	Innovad Group	BELGIUM	Animal Health
08/2025	WARBURG PINCUS	SEBIA	FRANCE	Diagnostic Equipment
08/2025	TERUMO	ORGANOX	UNITED KINGDOM	Medical Devices
07/2025	BC PARTNERS	BIOGARAN	FRANCE	Pharma & Biotech
07/2025	PATRICIA INDUSTRIES	NOVA BIOMEDICAL	UNITED STATES	Diagnostic Equipment

REFERENCES

Valuation range: EV 1b - 4b GBP

Revenue range: 450M - 900M GBP

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of DCC HEALTHCARE by INVESTCorporate are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: investcorporate